The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIL.L Regulatory News (MIL)

  • There is currently no data for MIL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Warrant Exercise Window

3 Mar 2021 16:31

RNS Number : 0831R
Myanmar Investments Intl Ltd
03 March 2021
 

3 March 2021

Myanmar Investments International LimitedWarrant Exercise Window

Myanmar Investments International Limited [AIM: MIL] ("MIL" or the "Company"), the AIM-quoted Myanmar focused investment company, announces that the window for warrant holders to exercise all or any of the warrants held by them on payment of a cash sum is now open and will remain open until 31 March 2021 (the "Exercise Window"). The terms applicable to the Exercise Window reflect the terms of the Warrant Instrument adopted on 21 May 2018 (the "Warrant Instrument"), a copy of which can be found on the Company's website at http://myanmarinvestments.com/shares-warrants-and-esops/.

Warrant holders are able to exercise their warrants for a cash payment of US$0.90 per share during the first calendar month of each Quarter (as defined in the Warrant Instrument) until 31 December 2021 whereupon all unexercised warrants will expire. A final opportunity for cashless conversion of warrants will also be available on 31 December 2021 (based on the NAV of the Company at that time).

Warrant holders who wish to exercise their warrants in the current Exercise Window should deliver the appropriate documentation to the Company in accordance with the requirements of clause 4 of the warrant instrument to arrive on or before 31 March 2021.

 

Application will be made to the London Stock Exchange for the admission of any Ordinary Shares issued on the exercise of the warrants to trading on AIM. It is anticipated that admission to trading of, and dealings in, the Ordinary Shares issued pursuant to the exercise of warrants in the Exercise Window, would commence on AIM no later than 10 business days following the close of the Exercise Window.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please contact: Nick Paris

Managing Director

Myanmar Investments International Ltd +95 (0) 1 391 804

nickparis@myanmarinvestments.com 

Nominated Adviser

Philip Secrett / Jamie Barklem / Seamus Fricker

Grant Thornton UK LLP

+44 (0) 20 7383 5100

Michael Rudolf

Chief Financial Officer

Myanmar Investments International Ltd

+95 (0) 1 391 804

michaelrudolf@myanmarinvestments.com 

Broker

William Marle / Giles Rolls

finnCap Ltd

+44 (0) 20 7220 0500

For more information about MIL, please visit www.myanmarinvestments.com 

 

Notes to Editors

Myanmar Investments International Limited (AIM: MIL) was the first Myanmar-focused investment company to be admitted to trading on the AIM market of the London Stock Exchange. MIL was established in 2013 with the intention of building long-term shareholder value by proactively investing in a diversified portfolio of Myanmar businesses that will benefit from the country's re-emergence and ongoing economic development. The Company is led by an experienced and entrepreneurial team who between them have considerable industrial, corporate and financial management experience. At the Annual General Meeting on 24 October 2019, the Company's shareholders approved a change in the investment policy of the Company to now seek to harvest the Company's investments over time.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKNBBABKDFNK
Date   Source Headline
4th Dec 20199:04 amRNSWarrant Exercise Window - Replacement
2nd Dec 20197:00 amRNSWarrant Exercise Window
28th Nov 20197:59 amRNSInterim results to 30 September 2019
25th Nov 20198:48 amRNSAppointment of Chief Financial Officer
24th Oct 20197:02 amRNSResult of AGM
15th Oct 20194:35 pmRNSBoard changes
10th Oct 20195:54 pmRNSBoard Change
30th Sep 20192:56 pmRNSPublication of the Annual Report and Notice of AGM
25th Sep 20199:55 amRNSAudited results for the year to 31 March 2019
2nd Sep 20197:00 amRNSChange of Accounting Reference Date
19th Jun 20197:00 amRNSShareholders' rejection of unsolicited approach
18th Jun 201912:53 pmRNSRejection of unsolicited approach
13th Jun 20195:26 pmRNSHolding(s) in Company
7th Jun 20192:00 pmRNSStrategic and Business Update
25th Mar 20199:28 amRNSClarification of Investment Restrictions
21st Jan 20192:35 pmRNSHolding(s) in Company
4th Jan 20197:00 amRNSLimited Exercise of Warrants
27th Dec 20189:17 amRNSDirectorate Change
3rd Dec 20187:00 amRNSWarrant Exercise Window
26th Nov 20183:59 pmRNSInterim results to 30 September 2018
18th Oct 20188:15 amRNSResults of AGM
27th Sep 20189:42 amRNSPosting of Annual Report & Accounts/Notice of AGM
21st Sep 20187:00 amRNSAudited results for the year to 31 March 2018
21st Sep 20187:00 amRNSUpdate on Apollo Towers
4th Sep 20187:00 amRNSHoldings in Company
26th Jun 20183:43 pmRNSExercise of Warrants
22nd May 20187:00 amRNSResults of General and Warrantholders Meetings
11th May 20187:00 amRNSAppointment of Corporate Broker
30th Apr 20187:00 amRNSStrategic and Business update
23rd Apr 20187:00 amRNSMFIL secures USD 6 million loan
22nd Mar 201812:45 pmRNSExtension of warrant exercise window
15th Feb 201810:29 amRNSHolding(s) in Company
25th Jan 201812:16 pmRNSExercise of Warrants
18th Jan 20187:00 amRNSPlanned Board change
24th Nov 20177:00 amRNSInterim results to 30 Sept 2017 & strategic update
26th Oct 20171:29 pmRNSExercise of Warrants
24th Oct 20171:54 pmRNSInvestment into the Tourism sector
18th Oct 20177:47 amRNSResult of AGM
25th Sep 20177:00 amRNSAudited results for the year to 31 March 2017
26th Jun 20179:53 amRNSMFIL secures loan through Symbiotics
21st Jun 20174:31 pmRNSAdditional equity raising of US$1 million
21st Jun 201710:46 amRNSDirector/PDMR Shareholding
19th Jun 20177:00 amRNSIssue of equity raising US$6.3 million
16th Jun 20174:31 pmRNSInstitutional Subscription and PrimaryBid Offer
26th May 20172:17 pmRNSInvestment into pharmacy joint venture
3rd May 20177:00 amRNSMFIL secures second loan from Maybank
28th Apr 20174:00 pmRNSExercise of Warrants
28th Apr 20177:00 amRNSPossible equity fundraising
10th Apr 20177:00 amRNSStrategic and Trading Update
25th Jan 20173:50 pmRNSExercise of warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.